NZ600454A - Fibronectin: growth factor chimeras - Google Patents
Fibronectin: growth factor chimerasInfo
- Publication number
- NZ600454A NZ600454A NZ600454A NZ60045410A NZ600454A NZ 600454 A NZ600454 A NZ 600454A NZ 600454 A NZ600454 A NZ 600454A NZ 60045410 A NZ60045410 A NZ 60045410A NZ 600454 A NZ600454 A NZ 600454A
- Authority
- NZ
- New Zealand
- Prior art keywords
- growth factor
- fibronectin
- igf
- insulin
- complex
- Prior art date
Links
- 108010067306 Fibronectins Proteins 0.000 title abstract 4
- 102000016359 Fibronectins Human genes 0.000 title 1
- 239000003102 growth factor Substances 0.000 title 1
- 102100037362 Fibronectin Human genes 0.000 abstract 3
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 3
- 102000013275 Somatomedins Human genes 0.000 abstract 2
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 abstract 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 1
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 abstract 1
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 abstract 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 abstract 1
- 101001055320 Myxine glutinosa Insulin-like growth factor Proteins 0.000 abstract 1
- 102000004584 Somatomedin Receptors Human genes 0.000 abstract 1
- 108010017622 Somatomedin Receptors Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000012292 cell migration Effects 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000006495 integrins Human genes 0.000 abstract 1
- 108010044426 integrins Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/627,647 US20100143442A1 (en) | 2003-02-05 | 2009-11-30 | Growth factor complexes and modulation of cell migration and growth |
| US12/793,386 US8871709B2 (en) | 2003-02-05 | 2010-06-03 | Synthetic chimeric proteins comprising epidermal growth factor and vitronectin |
| PCT/AU2010/001613 WO2011063477A1 (en) | 2009-11-30 | 2010-11-30 | Fibronectin: growth factor chimeras |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ600454A true NZ600454A (en) | 2014-10-31 |
Family
ID=44065756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ600454A NZ600454A (en) | 2009-11-30 | 2010-11-30 | Fibronectin: growth factor chimeras |
Country Status (12)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8871709B2 (en) | 2003-02-05 | 2014-10-28 | Queensland University of Technolgy | Synthetic chimeric proteins comprising epidermal growth factor and vitronectin |
| CN103834664B (zh) * | 2014-03-27 | 2016-05-04 | 吉林大学 | 重组表皮生长因子egf及其制备方法 |
| CN110023325B (zh) * | 2016-10-14 | 2023-07-04 | 尼优美特里克斯医疗有限公司 | 具有提高的生物活性和降低的对嗜中性粒细胞弹性蛋白酶降解易感性的来源于纤连蛋白的肽 |
| WO2019010533A1 (en) * | 2017-07-12 | 2019-01-17 | Factor Therapeutics Limited | TREATMENT OF OCULAR DISORDERS |
| CN110123732A (zh) * | 2019-04-03 | 2019-08-16 | 广州市拉凯尔干细胞研究所 | 一种含有纤连蛋白化妆品原料制备方法 |
| CN114040923B (zh) * | 2019-04-05 | 2024-11-26 | 韩国窑业技术院 | 利用肌集钙蛋白标签的蛋白质的表达及纯化方法 |
| KR102440312B1 (ko) * | 2020-08-28 | 2022-09-05 | 한국해양과학기술원 | 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도 |
| CN119264240B (zh) * | 2024-09-10 | 2025-03-25 | 浙江诸暨聚源生物技术有限公司 | 功能增强的重组纤连蛋白及其制备方法和应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4843000A (en) | 1979-12-26 | 1989-06-27 | Syntex (U.S.A.) Inc. | Simultaneous calibration heterogeneous immunoassay |
| US4849338A (en) | 1982-07-16 | 1989-07-18 | Syntex (U.S.A.) Inc. | Simultaneous calibration heterogeneous immunoassay |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| JP3178714B2 (ja) | 1988-07-15 | 2001-06-25 | セントラル・シドニー・エリア・ヘルス・サービス | インスリン様成長因子（ｉｇｆ）結合蛋白複合体の酸不安定サブユニット（ａｌｓ） |
| US6090790A (en) | 1989-12-14 | 2000-07-18 | Eriksson; Elof | Gene delivery by microneedle injection |
| JP2866134B2 (ja) * | 1990-02-05 | 1999-03-08 | 寳酒造株式会社 | 機能性ポリペプチド |
| AU649066B2 (en) | 1990-07-25 | 1994-05-12 | Syngene, Inc. | Circular extension for generating multiple nucleic acid complements |
| US6054122A (en) | 1990-11-27 | 2000-04-25 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
| JP2829405B2 (ja) * | 1991-10-14 | 1998-11-25 | 寳酒造株式会社 | 機能性ポリペプチド |
| US5958764A (en) | 1992-04-30 | 1999-09-28 | Baylor College Of Medicine | Specific expression vectors and methods of use |
| WO1994018232A1 (en) | 1993-02-12 | 1994-08-18 | Repligen Corporation | Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same |
| US5422252A (en) | 1993-06-04 | 1995-06-06 | Becton, Dickinson And Company | Simultaneous amplification of multiple targets |
| US5962427A (en) | 1994-02-18 | 1999-10-05 | The Regent Of The University Of Michigan | In vivo gene transfer methods for wound healing |
| AUPM672594A0 (en) | 1994-07-08 | 1994-08-04 | Royal Children's Hospital Research Foundation | A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| ATE195555T1 (de) * | 1994-11-29 | 2000-09-15 | Takara Shuzo Co | Verfahren zur herstellung transformierter zellen |
| AU709831B2 (en) * | 1995-11-13 | 1999-09-09 | Takara Bio Inc. | Method for gene transfer into target cells with retrovirus |
| DK0862656T3 (da) | 1995-11-21 | 2001-04-09 | Univ Yale | Unimolekylær segmentamplifikation og -detektering |
| US5752019A (en) | 1995-12-22 | 1998-05-12 | International Business Machines Corporation | System and method for confirmationally-flexible molecular identification |
| US5835382A (en) | 1996-04-26 | 1998-11-10 | The Scripps Research Institute | Small molecule mimetics of erythropoietin |
| US6077987A (en) | 1997-09-04 | 2000-06-20 | North Shore-Long Island Jewish Research Institute | Genetic engineering of cells to enhance healing and tissue regeneration |
| WO1999047070A1 (en) | 1998-03-18 | 1999-09-23 | Wake Forest University | Improved implantable biomaterials, compositions and methods for their preparation and uses thereof |
| AUPP298498A0 (en) | 1998-04-17 | 1998-05-07 | Gropep Pty Ltd | Matrix binding factor |
| US6436897B2 (en) | 1998-06-01 | 2002-08-20 | Celtrix Pharmaceuticals, Inc. | Pharmaceutical formulations for IGF/IGFBP |
| AU3897200A (en) | 1999-03-18 | 2000-10-04 | Hope Heart Institute, The | Endothelial cell stimulation by a complex of fibronectin and vascular endothelial growth factor |
| AU2003900481A0 (en) * | 2003-02-05 | 2003-02-20 | Queensland University Of Technology | Synthetic modulators of cell migration and growth |
| JP2008125460A (ja) * | 2006-11-22 | 2008-06-05 | Institute Of Physical & Chemical Research | フィブリン結合性成長因子 |
| CA2690734A1 (en) * | 2007-06-14 | 2008-12-24 | Richard A. Clark | Polypeptides and methods of use |
-
2010
- 2010-11-30 AU AU2010324554A patent/AU2010324554B2/en not_active Ceased
- 2010-11-30 ES ES10832439.3T patent/ES2619938T3/es active Active
- 2010-11-30 CN CN201080062313XA patent/CN102725308A/zh active Pending
- 2010-11-30 RU RU2012127364/10A patent/RU2012127364A/ru not_active Application Discontinuation
- 2010-11-30 EP EP10832439.3A patent/EP2507261B1/en not_active Not-in-force
- 2010-11-30 JP JP2012540231A patent/JP2013511960A/ja active Pending
- 2010-11-30 CA CA2781474A patent/CA2781474C/en not_active Expired - Fee Related
- 2010-11-30 BR BR112012013035A patent/BR112012013035A8/pt not_active Application Discontinuation
- 2010-11-30 NZ NZ600454A patent/NZ600454A/en not_active IP Right Cessation
- 2010-11-30 KR KR1020127016766A patent/KR101930916B1/ko not_active Expired - Fee Related
- 2010-11-30 WO PCT/AU2010/001613 patent/WO2011063477A1/en not_active Ceased
-
2012
- 2012-05-29 ZA ZA2012/03915A patent/ZA201203915B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010324554A1 (en) | 2012-06-21 |
| EP2507261B1 (en) | 2016-12-21 |
| EP2507261A1 (en) | 2012-10-10 |
| CA2781474C (en) | 2019-06-18 |
| ES2619938T3 (es) | 2017-06-27 |
| JP2013511960A (ja) | 2013-04-11 |
| RU2012127364A (ru) | 2014-01-10 |
| KR101930916B1 (ko) | 2018-12-19 |
| EP2507261A4 (en) | 2013-04-10 |
| CA2781474A1 (en) | 2011-06-03 |
| KR20120114277A (ko) | 2012-10-16 |
| BR112012013035A8 (pt) | 2018-04-03 |
| WO2011063477A1 (en) | 2011-06-03 |
| BR112012013035A2 (pt) | 2017-05-16 |
| AU2010324554B2 (en) | 2014-07-31 |
| ZA201203915B (en) | 2018-11-28 |
| CN102725308A (zh) | 2012-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283597A (en) | A pluripotent stem cell growth medium containing human serum and without a nutrient layer | |
| CA2695225C (en) | Differentiation of human embryonic stem cells to pancreatic endocrine | |
| MX2010000746A (es) | Diferenciacion de celulas madre embrionarias humanas. | |
| WO2007127927A3 (en) | Differentiation of human embryonic stem cells | |
| WO2009149161A3 (en) | Chimeric natriuretic polypeptides and methods for inhibiting cardiac remodeling | |
| WO2008124166A8 (en) | Fusion proteins of collagen-binding domain and parathyroid hormone | |
| WO2009132063A3 (en) | Pluripotent cells | |
| WO2010090513A3 (en) | Culture medium for epithelial stem cells and organoids comprising said stem cells. | |
| ATE523585T1 (de) | Differenzierung menschlicher embryonaler stammzellen | |
| WO2010129853A3 (en) | TRANSDUCIBLE DELIVERY OF NUCLEIC ACIDS USING MODIFIED dsRNA BINDING DOMAINS | |
| WO2011140397A3 (en) | Stem cell defined media for xeno-free and feeder free conditions and uses thereof | |
| CL2012001258A1 (es) | Un polipeptido de factor de von willebrand (fvw) aislado que comprende un dominio de union a factor viii (fviii), donde dicho polipeptido carece de algunos dominios del fvw, comprende una secuencia de aminoacidos de fc de inmunoglobulina; composicion y complejo proteico que lo comprende; celula que expresa dicho polipeptido; celula que expresa dicho complejo proteico; composición que comprende el complejo proteico. | |
| CA2924816A1 (en) | A method to direct differentiation of pluripotent stem cells into functional heart muscle | |
| MX2010008099A (es) | Anticuerpos y angiopoyetina-2 estabilizados y sus usos. | |
| EP2064324A4 (en) | SUBSTRATES FOR CELL CULTURE AND MANUFACTURING METHOD THEREFOR | |
| MX2012009175A (es) | Metodos para identificar y aislar celulas que expresan un polipeptido. | |
| SG10201603901UA (en) | Methods For Enriching Pluripotent Stem Cell-Derived Cardiomyocyte Progenitor Cells And Cardiomyocyte Cells Based On Sirpa Expression | |
| WO2011153276A3 (en) | Stable, functional chimeric cellobiohydrolase class i enzymes | |
| WO2010131821A1 (ko) | 줄기세포에 대한 접착활성을 갖는 섬유아세포 성장인자의 재조합 단백질 및 이를 이용한 줄기세포의 배양방법 | |
| BRPI0921996A2 (pt) | Métodos e composições para cultura e ligação de células em substratos planos. | |
| IL220564A (en) | You'll notice mrm / srm for protein receptor-like insulin-like growth factor - 1 (r1 - igf) | |
| WO2011024070A3 (en) | Composition and method for proliferating undifferentiated stem cells | |
| WO2008152422A3 (en) | Binding proteins specific for insulin-like growth factors and uses thereof-909 | |
| EA201200186A1 (ru) | Вектор, содержащий промотор маннозы, и промотор маннозы | |
| WO2009126932A3 (en) | Fortified liquid protein compositions and methods of making same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 30 NOV 2017 BY DAVIES COLLISON CAVE Effective date: 20150203 |
|
| ASS | Change of ownership |
Owner name: TISSUE THERAPIES LIMITED, AU Effective date: 20150820 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2018 BY FPA PATENT ATTORNEYS PTY LTD Effective date: 20171030 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2019 BY FPA PATENT ATTORNEYS PTY LTD Effective date: 20180830 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2020 BY FPA PATENT ATTORNEYS PTY LTD Effective date: 20191004 |
|
| LAPS | Patent lapsed |